 | • レポートコード：D0GIR-00956 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、結核感染検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。結核感染検査の種類別市場規模（ツベルクリン皮膚試験（TST）、インターフェロンガンマリリースアッセイ（IGRA）、その他）、用途別市場規模（病院・診療所、診断検査室、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Danaher、Hologic、Qiagen、Becton Dickinson、Oxford Immunotec、Bio-Rad、Genedrive plc、Roche、Thermo Fisher Scientific、Hain Lifescience、Akonni Biosystems、Creative Diagnostics ・地域別グローバル市場分析 2015年-2020年 ・結核感染検査の北米市場（アメリカ、カナダ、メキシコ） ・結核感染検査のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・結核感染検査のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・結核感染検査の南米市場（ブラジル、アルゼンチン） ・結核感染検査の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ツベルクリン皮膚試験（TST）、インターフェロンガンマリリースアッセイ（IGRA）、その他 ・用途別分析：病院・診療所、診断検査室、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Tuberculosis Infection Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Tuberculosis Infection Testing sales will be xx in 2020 from Tuberculosis Infection Testing million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Tuberculosis Infection Testing market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Tuberculosis Infection Testing industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Tuberculosis Infection Testing and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Tuberculosis Infection Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Tuberculosis Infection Testing market has been segmented into:
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Others
By Application, Tuberculosis Infection Testing has been segmented into:
Hospitals and Clinics
Diagnostic Laboratories
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tuberculosis Infection Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Tuberculosis Infection Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tuberculosis Infection Testing market.
The report offers in-depth assessment of the growth and other aspects of the Tuberculosis Infection Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Tuberculosis Infection Testing Market Share Analysis
Tuberculosis Infection Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tuberculosis Infection Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tuberculosis Infection Testing sales, revenue and market share for each player covered in this report.
The major players covered in Tuberculosis Infection Testing are:
Danaher
Hologic
Qiagen
Becton Dickinson
Oxford Immunotec
Bio-Rad
Genedrive plc
Roche
Thermo Fisher Scientific
Hain Lifescience
Akonni Biosystems
Creative Diagnostics
Among other players domestic and global, Tuberculosis Infection Testing market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Tuberculosis Infection Testing Market Overview
1.1 Product Overview and Scope of Tuberculosis Infection Testing
1.2 Classification of Tuberculosis Infection Testing by Type
1.2.1 Global Tuberculosis Infection Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Tuberculosis Infection Testing Revenue Market Share by Type in 2019
1.2.3 Tuberculin Skin Test (TST)
1.2.4 Interferon Gamma Released Assay (IGRA)
1.2.5 Others
1.3 Global Tuberculosis Infection Testing Market by Application
1.3.1 Overview: Global Tuberculosis Infection Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Global Tuberculosis Infection Testing Market by Regions
1.4.1 Global Tuberculosis Infection Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Tuberculosis Infection Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Tuberculosis Infection Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Tuberculosis Infection Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tuberculosis Infection Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Tuberculosis Infection Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tuberculosis Infection Testing Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Tuberculosis Infection Testing Industry Impact
1.5.1 COVID-19 Potential Implications for the Tuberculosis Infection Testing
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Tuberculosis Infection Testing
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Danaher
2.1.1 Danaher Details
2.1.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Danaher SWOT Analysis
2.1.4 Danaher Product and Services
2.1.5 Danaher Tuberculosis Infection Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hologic
2.2.1 Hologic Details
2.2.2 Hologic Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Hologic SWOT Analysis
2.2.4 Hologic Product and Services
2.2.5 Hologic Tuberculosis Infection Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Qiagen
2.3.1 Qiagen Details
2.3.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Qiagen SWOT Analysis
2.3.4 Qiagen Product and Services
2.3.5 Qiagen Tuberculosis Infection Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Becton Dickinson
2.4.1 Becton Dickinson Details
2.4.2 Becton Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Becton Dickinson SWOT Analysis
2.4.4 Becton Dickinson Product and Services
2.4.5 Becton Dickinson Tuberculosis Infection Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Oxford Immunotec
2.5.1 Oxford Immunotec Details
2.5.2 Oxford Immunotec Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Oxford Immunotec SWOT Analysis
2.5.4 Oxford Immunotec Product and Services
2.5.5 Oxford Immunotec Tuberculosis Infection Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bio-Rad
2.6.1 Bio-Rad Details
2.6.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bio-Rad SWOT Analysis
2.6.4 Bio-Rad Product and Services
2.6.5 Bio-Rad Tuberculosis Infection Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Genedrive plc
2.7.1 Genedrive plc Details
2.7.2 Genedrive plc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Genedrive plc SWOT Analysis
2.7.4 Genedrive plc Product and Services
2.7.5 Genedrive plc Tuberculosis Infection Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Roche SWOT Analysis
2.8.4 Roche Product and Services
2.8.5 Roche Tuberculosis Infection Testing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Thermo Fisher Scientific
2.9.1 Thermo Fisher Scientific Details
2.9.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Thermo Fisher Scientific SWOT Analysis
2.9.4 Thermo Fisher Scientific Product and Services
2.9.5 Thermo Fisher Scientific Tuberculosis Infection Testing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Hain Lifescience
2.10.1 Hain Lifescience Details
2.10.2 Hain Lifescience Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Hain Lifescience SWOT Analysis
2.10.4 Hain Lifescience Product and Services
2.10.5 Hain Lifescience Tuberculosis Infection Testing Revenue, Gross Margin and Market Share (2018-2019)
2.11 Akonni Biosystems
2.11.1 Akonni Biosystems Details
2.11.2 Akonni Biosystems Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Akonni Biosystems SWOT Analysis
2.11.4 Akonni Biosystems Product and Services
2.11.5 Akonni Biosystems Tuberculosis Infection Testing Revenue, Gross Margin and Market Share (2018-2019)
2.12 Creative Diagnostics
2.12.1 Creative Diagnostics Details
2.12.2 Creative Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Creative Diagnostics SWOT Analysis
2.12.4 Creative Diagnostics Product and Services
2.12.5 Creative Diagnostics Tuberculosis Infection Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Tuberculosis Infection Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Tuberculosis Infection Testing Players Market Share
3.2.2 Top 10 Tuberculosis Infection Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Tuberculosis Infection Testing Revenue and Market Share by Regions
4.2 North America Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
4.5 South America Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
5 North America Tuberculosis Infection Testing Revenue by Countries
5.1 North America Tuberculosis Infection Testing Revenue by Countries (2015-2020)
5.2 USA Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
6 Europe Tuberculosis Infection Testing Revenue by Countries
6.1 Europe Tuberculosis Infection Testing Revenue by Countries (2015-2020)
6.2 Germany Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
6.3 UK Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
6.4 France Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Tuberculosis Infection Testing Revenue by Countries
7.1 Asia-Pacific Tuberculosis Infection Testing Revenue by Countries (2015-2020)
7.2 China Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
7.5 India Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
8 South America Tuberculosis Infection Testing Revenue by Countries
8.1 South America Tuberculosis Infection Testing Revenue by Countries (2015-2020)
8.2 Brazil Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Tuberculosis Infection Testing by Countries
9.1 Middle East & Africa Tuberculosis Infection Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Tuberculosis Infection Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Tuberculosis Infection Testing Market Forecast by Type (2019-2024)
10.3 Tuberculin Skin Test (TST) Revenue Growth Rate (2015-2025)
10.4 Interferon Gamma Released Assay (IGRA) Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Tuberculosis Infection Testing Market Segment by Application
11.1 Global Tuberculosis Infection Testing Revenue Market Share by Application (2015-2020)
11.2 Tuberculosis Infection Testing Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2015-2020)
11.4 Diagnostic Laboratories Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Tuberculosis Infection Testing Market Size Forecast (2021-2025)
12.1 Global Tuberculosis Infection Testing Market Size Forecast (2021-2025)
12.2 Global Tuberculosis Infection Testing Market Forecast by Regions (2021-2025)
12.3 North America Tuberculosis Infection Testing Revenue Market Forecast (2021-2025)
12.4 Europe Tuberculosis Infection Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Tuberculosis Infection Testing Revenue Market Forecast (2021-2025)
12.6 South America Tuberculosis Infection Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Tuberculosis Infection Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Tuberculosis Infection Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tuberculosis Infection Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tuberculosis Infection Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Tuberculosis Infection Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Tuberculosis Infection Testing Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Danaher Corporate Information, Location and Competitors
Table 7. Danaher Tuberculosis Infection Testing Major Business
Table 8. Danaher Tuberculosis Infection Testing Total Revenue (USD Million) (2017-2018)
Table 9. Danaher SWOT Analysis
Table 10. Danaher Tuberculosis Infection Testing Product and Solutions
Table 11. Danaher Tuberculosis Infection Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Hologic Corporate Information, Location and Competitors
Table 13. Hologic Tuberculosis Infection Testing Major Business
Table 14. Hologic Tuberculosis Infection Testing Total Revenue (USD Million) (2018-2019)
Table 15. Hologic SWOT Analysis
Table 16. Hologic Tuberculosis Infection Testing Product and Solutions
Table 17. Hologic Tuberculosis Infection Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Qiagen Corporate Information, Location and Competitors
Table 19. Qiagen Tuberculosis Infection Testing Major Business
Table 20. Qiagen Tuberculosis Infection Testing Total Revenue (USD Million) (2017-2018)
Table 21. Qiagen SWOT Analysis
Table 22. Qiagen Tuberculosis Infection Testing Product and Solutions
Table 23. Qiagen Tuberculosis Infection Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Becton Dickinson Corporate Information, Location and Competitors
Table 25. Becton Dickinson Tuberculosis Infection Testing Major Business
Table 26. Becton Dickinson Tuberculosis Infection Testing Total Revenue (USD Million) (2017-2018)
Table 27. Becton Dickinson SWOT Analysis
Table 28. Becton Dickinson Tuberculosis Infection Testing Product and Solutions
Table 29. Becton Dickinson Tuberculosis Infection Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Oxford Immunotec Corporate Information, Location and Competitors
Table 31. Oxford Immunotec Tuberculosis Infection Testing Major Business
Table 32. Oxford Immunotec Tuberculosis Infection Testing Total Revenue (USD Million) (2017-2018)
Table 33. Oxford Immunotec SWOT Analysis
Table 34. Oxford Immunotec Tuberculosis Infection Testing Product and Solutions
Table 35. Oxford Immunotec Tuberculosis Infection Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Bio-Rad Corporate Information, Location and Competitors
Table 37. Bio-Rad Tuberculosis Infection Testing Major Business
Table 38. Bio-Rad Tuberculosis Infection Testing Total Revenue (USD Million) (2017-2018)
Table 39. Bio-Rad SWOT Analysis
Table 40. Bio-Rad Tuberculosis Infection Testing Product and Solutions
Table 41. Bio-Rad Tuberculosis Infection Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Genedrive plc Corporate Information, Location and Competitors
Table 43. Genedrive plc Tuberculosis Infection Testing Major Business
Table 44. Genedrive plc Tuberculosis Infection Testing Total Revenue (USD Million) (2017-2018)
Table 45. Genedrive plc SWOT Analysis
Table 46. Genedrive plc Tuberculosis Infection Testing Product and Solutions
Table 47. Genedrive plc Tuberculosis Infection Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Roche Corporate Information, Location and Competitors
Table 49. Roche Tuberculosis Infection Testing Major Business
Table 50. Roche Tuberculosis Infection Testing Total Revenue (USD Million) (2017-2018)
Table 51. Roche SWOT Analysis
Table 52. Roche Tuberculosis Infection Testing Product and Solutions
Table 53. Roche Tuberculosis Infection Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 55. Thermo Fisher Scientific Tuberculosis Infection Testing Major Business
Table 56. Thermo Fisher Scientific Tuberculosis Infection Testing Total Revenue (USD Million) (2017-2018)
Table 57. Thermo Fisher Scientific SWOT Analysis
Table 58. Thermo Fisher Scientific Tuberculosis Infection Testing Product and Solutions
Table 59. Thermo Fisher Scientific Tuberculosis Infection Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Hain Lifescience Corporate Information, Location and Competitors
Table 61. Hain Lifescience Tuberculosis Infection Testing Major Business
Table 62. Hain Lifescience Tuberculosis Infection Testing Total Revenue (USD Million) (2017-2018)
Table 63. Hain Lifescience SWOT Analysis
Table 64. Hain Lifescience Tuberculosis Infection Testing Product and Solutions
Table 65. Hain Lifescience Tuberculosis Infection Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Akonni Biosystems Corporate Information, Location and Competitors
Table 67. Akonni Biosystems Tuberculosis Infection Testing Major Business
Table 68. Akonni Biosystems Tuberculosis Infection Testing Total Revenue (USD Million) (2017-2018)
Table 69. Akonni Biosystems SWOT Analysis
Table 70. Akonni Biosystems Tuberculosis Infection Testing Product and Solutions
Table 71. Akonni Biosystems Tuberculosis Infection Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Creative Diagnostics Corporate Information, Location and Competitors
Table 73. Creative Diagnostics Tuberculosis Infection Testing Major Business
Table 74. Creative Diagnostics Tuberculosis Infection Testing Total Revenue (USD Million) (2017-2018)
Table 75. Creative Diagnostics SWOT Analysis
Table 76. Creative Diagnostics Tuberculosis Infection Testing Product and Solutions
Table 77. Creative Diagnostics Tuberculosis Infection Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Global Tuberculosis Infection Testing Revenue (Million USD) by Players (2015-2020)
Table 79. Global Tuberculosis Infection Testing Revenue Share by Players (2015-2020)
Table 80. Global Tuberculosis Infection Testing Revenue (Million USD) by Regions (2015-2020)
Table 81. Global Tuberculosis Infection Testing Revenue Market Share by Regions (2015-2020)
Table 82. North America Tuberculosis Infection Testing Revenue by Countries (2015-2020)
Table 83. North America Tuberculosis Infection Testing Revenue Market Share by Countries (2015-2020)
Table 84. Europe Tuberculosis Infection Testing Revenue (Million USD) by Countries (2015-2020)
Table 85. Asia-Pacific Tuberculosis Infection Testing Revenue (Million USD) by Countries (2015-2020)
Table 86. South America Tuberculosis Infection Testing Revenue by Countries (2015-2020)
Table 87. South America Tuberculosis Infection Testing Revenue Market Share by Countries (2015-2020)
Table 88. Middle East and Africa Tuberculosis Infection Testing Revenue (Million USD) by Countries (2015-2020)
Table 89. Middle East and Africa Tuberculosis Infection Testing Revenue Market Share by Countries (2015-2020)
Table 90. Global Tuberculosis Infection Testing Revenue (Million USD) by Type (2015-2020)
Table 91. Global Tuberculosis Infection Testing Revenue Share by Type (2015-2020)
Table 92. Global Tuberculosis Infection Testing Revenue Forecast by Type (2021-2025)
Table 93. Global Tuberculosis Infection Testing Revenue by Application (2015-2020)
Table 94. Global Tuberculosis Infection Testing Revenue Share by Application (2015-2020)
Table 95. Global Tuberculosis Infection Testing Revenue Forecast by Application (2021-2025)
Table 96. Global Tuberculosis Infection Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Tuberculosis Infection Testing Picture
Figure 2. Global Tuberculosis Infection Testing Revenue Market Share by Type in 2019
Figure 3. Tuberculin Skin Test (TST) Picture
Figure 4. Interferon Gamma Released Assay (IGRA) Picture
Figure 5. Others Picture
Figure 6. Tuberculosis Infection Testing Revenue Market Share by Application in 2019
Figure 7. Hospitals and Clinics Picture
Figure 8. Diagnostic Laboratories Picture
Figure 9. Others Picture
Figure 10. Global Tuberculosis Infection Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Tuberculosis Infection Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Tuberculosis Infection Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Tuberculosis Infection Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Tuberculosis Infection Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Tuberculosis Infection Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Tuberculosis Infection Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Tuberculosis Infection Testing Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Tuberculosis Infection Testing Revenue Market Share in 2019
Figure 19. Global Top 10 Players Tuberculosis Infection Testing Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Tuberculosis Infection Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Tuberculosis Infection Testing Revenue Market Share by Regions (2015-2020)
Figure 23. Global Tuberculosis Infection Testing Revenue Market Share by Regions in 2018
Figure 24. North America Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 25. Europe Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 27. South America Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 29. North America Tuberculosis Infection Testing Revenue Market Share by Countries (2015-2020)
Figure 30. North America Tuberculosis Infection Testing Revenue Market Share by Countries in 2019
Figure 31. USA Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 32. Canada Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 34. Europe Tuberculosis Infection Testing Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Tuberculosis Infection Testing Revenue Market Share by Countries in 2019
Figure 36. Germany Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 37. UK Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 38. France Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 39. Russia Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 40. Italy Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Tuberculosis Infection Testing Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Tuberculosis Infection Testing Revenue Market Share by Countries in 2019
Figure 43. China Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 44. Japan Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 45. Korea Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 46. India Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 48. South America Tuberculosis Infection Testing Revenue Market Share by Countries (2015-2020)
Figure 49. South America Tuberculosis Infection Testing Revenue Market Share by Countries in 2019
Figure 50. Brazil Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Tuberculosis Infection Testing Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Tuberculosis Infection Testing Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 55. UAE Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Tuberculosis Infection Testing Revenue and Growth Rate (2015-2020)
Figure 58. Global Tuberculosis Infection Testing Revenue Share by Type (2015-2020)
Figure 59. Global Tuberculosis Infection Testing Revenue Share by Type in 2019
Figure 60. Global Tuberculosis Infection Testing Market Share Forecast by Type (2021-2025)
Figure 61. Global Tuberculin Skin Test (TST) Revenue Growth Rate (2015-2020)
Figure 62. Global Interferon Gamma Released Assay (IGRA) Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Tuberculosis Infection Testing Revenue Share by Application (2015-2020)
Figure 65. Global Tuberculosis Infection Testing Revenue Share by Application in 2019
Figure 66. Global Tuberculosis Infection Testing Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals and Clinics Revenue Growth Rate (2015-2020)
Figure 68. Global Diagnostic Laboratories Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Tuberculosis Infection Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Tuberculosis Infection Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Tuberculosis Infection Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Tuberculosis Infection Testing Revenue Market Forecast (2021-2025)
Figure 74. Europe Tuberculosis Infection Testing Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Tuberculosis Infection Testing Revenue Market Forecast (2021-2025)
Figure 76. South America Tuberculosis Infection Testing Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Tuberculosis Infection Testing Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
結核検査・診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Tuberculosis Testing and Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…- 院内感染管理の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Hospital Acquired Infection Control market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1179.1 million by 2025, from USD 1068.4 million in 2019. The …
- 結核診断・治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Tuberculosis Diagnosis and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tubercul…
- 感染症迅速診断検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Infectious Disease Rapid Diagnostic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…
- 結核ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tuberculosis Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tuberculosis Vaccines m…